Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.88382949 |
2 | neutrophil activation involved in immune response (GO:0002283) | 4.47069083 |
3 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.24468584 |
4 | response to peptidoglycan (GO:0032494) | 4.23716921 |
5 | proteasome assembly (GO:0043248) | 4.17559680 |
6 | positive regulation of interferon-alpha production (GO:0032727) | 4.13579134 |
7 | T-helper 1 type immune response (GO:0042088) | 4.01118497 |
8 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.92299257 |
9 | piRNA metabolic process (GO:0034587) | 3.91766866 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91574917 |
11 | response to type I interferon (GO:0034340) | 3.91451056 |
12 | cellular response to type I interferon (GO:0071357) | 3.90268942 |
13 | type I interferon signaling pathway (GO:0060337) | 3.90268942 |
14 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.89444472 |
15 | regulation of interferon-alpha production (GO:0032647) | 3.86771129 |
16 | response to interferon-beta (GO:0035456) | 3.86667246 |
17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.80425618 |
18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76133864 |
19 | mannosylation (GO:0097502) | 3.73994872 |
20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.73889752 |
21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73889752 |
22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.72126614 |
23 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.71697692 |
24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.71647826 |
25 | detection of molecule of bacterial origin (GO:0032490) | 3.67448231 |
26 | cellular response to interferon-beta (GO:0035458) | 3.66863060 |
27 | platelet dense granule organization (GO:0060155) | 3.64136051 |
28 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.61980547 |
29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61466907 |
30 | response to interferon-alpha (GO:0035455) | 3.54961360 |
31 | negative regulation of interleukin-17 production (GO:0032700) | 3.53893348 |
32 | detection of other organism (GO:0098543) | 3.51051634 |
33 | nucleotide transmembrane transport (GO:1901679) | 3.48585084 |
34 | positive regulation of interleukin-12 production (GO:0032735) | 3.48026617 |
35 | neural tube formation (GO:0001841) | 3.45917300 |
36 | DNA deamination (GO:0045006) | 3.43538782 |
37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42582036 |
38 | positive regulation of interferon-beta production (GO:0032728) | 3.39143345 |
39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36563494 |
40 | modulation by symbiont of host defense response (GO:0052031) | 3.36563494 |
41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36563494 |
42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36563494 |
43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36563494 |
44 | modulation by symbiont of host immune response (GO:0052553) | 3.36563494 |
45 | immunoglobulin mediated immune response (GO:0016064) | 3.34363096 |
46 | negative regulation of viral genome replication (GO:0045071) | 3.29482143 |
47 | neutrophil activation (GO:0042119) | 3.27325323 |
48 | regulation of meiosis I (GO:0060631) | 3.26688513 |
49 | myeloid dendritic cell activation (GO:0001773) | 3.25878966 |
50 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.25835601 |
51 | myeloid dendritic cell differentiation (GO:0043011) | 3.24187962 |
52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23275458 |
53 | granulocyte activation (GO:0036230) | 3.22545781 |
54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.22211999 |
55 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.20178686 |
56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19393872 |
57 | regulation of activation of Janus kinase activity (GO:0010533) | 3.19277666 |
58 | superoxide anion generation (GO:0042554) | 3.18486378 |
59 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.18238892 |
60 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.17578284 |
61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14165030 |
62 | cellular response to zinc ion (GO:0071294) | 3.14083852 |
63 | regulation of RIG-I signaling pathway (GO:0039535) | 3.12397943 |
64 | detection of external biotic stimulus (GO:0098581) | 3.11925293 |
65 | NIK/NF-kappaB signaling (GO:0038061) | 3.07401285 |
66 | regulation of fever generation (GO:0031620) | 3.07096258 |
67 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.04476490 |
68 | GPI anchor metabolic process (GO:0006505) | 3.03810278 |
69 | regulation of natural killer cell differentiation (GO:0032823) | 3.03044354 |
70 | GPI anchor biosynthetic process (GO:0006506) | 2.98986559 |
71 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98720769 |
72 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.97819199 |
73 | positive regulation of heat generation (GO:0031652) | 2.97167157 |
74 | regulation of chemokine biosynthetic process (GO:0045073) | 2.97151646 |
75 | membrane budding (GO:0006900) | 2.95037766 |
76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.94634279 |
77 | leukocyte aggregation (GO:0070486) | 2.94122596 |
78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.93600107 |
79 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.92335635 |
80 | isotype switching (GO:0045190) | 2.92335635 |
81 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.92335635 |
82 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.91135885 |
83 | protein K11-linked deubiquitination (GO:0035871) | 2.90380151 |
84 | response to muramyl dipeptide (GO:0032495) | 2.88371442 |
85 | B cell mediated immunity (GO:0019724) | 2.87903908 |
86 | regulation of interleukin-17 production (GO:0032660) | 2.87337693 |
87 | reactive oxygen species biosynthetic process (GO:1903409) | 2.86739885 |
88 | interferon-gamma production (GO:0032609) | 2.86638008 |
89 | negative regulation of acute inflammatory response (GO:0002674) | 2.85396978 |
90 | synapsis (GO:0007129) | 2.85363170 |
91 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.84711491 |
92 | respiratory burst (GO:0045730) | 2.83260096 |
93 | C-terminal protein lipidation (GO:0006501) | 2.78961510 |
94 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.78934891 |
95 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.78934891 |
96 | sequestering of actin monomers (GO:0042989) | 2.77753398 |
97 | positive regulation of interleukin-2 production (GO:0032743) | 2.77612907 |
98 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.73908643 |
99 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.73826644 |
100 | regulation of fibroblast apoptotic process (GO:2000269) | 2.71909002 |
101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71505947 |
102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.69807104 |
103 | detection of biotic stimulus (GO:0009595) | 2.69774163 |
104 | peptidyl-histidine modification (GO:0018202) | 2.69374279 |
105 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.67762718 |
106 | regulation of interleukin-12 production (GO:0032655) | 2.67180781 |
107 | macrophage activation involved in immune response (GO:0002281) | 2.67109194 |
108 | protein prenylation (GO:0018342) | 2.66083809 |
109 | prenylation (GO:0097354) | 2.66083809 |
110 | natural killer cell mediated immunity (GO:0002228) | 2.65382557 |
111 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.65382557 |
112 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.65217665 |
113 | positive regulation of humoral immune response (GO:0002922) | 2.64505453 |
114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.63843425 |
115 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.63101837 |
116 | cullin deneddylation (GO:0010388) | 2.62996563 |
117 | signal peptide processing (GO:0006465) | 2.62564649 |
118 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.62532937 |
119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.61885670 |
120 | regulation of gamma-delta T cell activation (GO:0046643) | 2.60879817 |
121 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.60874472 |
122 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.60874472 |
123 | regulation of natural killer cell activation (GO:0032814) | 2.60718726 |
124 | natural killer cell activation (GO:0030101) | 2.60082452 |
125 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59942809 |
126 | ribonucleoprotein complex disassembly (GO:0032988) | 2.59863353 |
127 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.59336718 |
128 | dendritic cell differentiation (GO:0097028) | 2.58814589 |
129 | cellular response to exogenous dsRNA (GO:0071360) | 2.58525994 |
130 | defense response to protozoan (GO:0042832) | 2.58485478 |
131 | positive regulation of B cell differentiation (GO:0045579) | 2.57571111 |
132 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.56708611 |
133 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.55746570 |
134 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.54685541 |
135 | histone H2A ubiquitination (GO:0033522) | 2.54588294 |
136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54555434 |
137 | wound healing, spreading of epidermal cells (GO:0035313) | 2.54221030 |
138 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.53536435 |
139 | positive regulation of response to biotic stimulus (GO:0002833) | 2.53145082 |
140 | adenosine metabolic process (GO:0046085) | 2.52678650 |
141 | DNA double-strand break processing (GO:0000729) | 2.48177305 |
142 | B cell activation involved in immune response (GO:0002312) | 2.47100614 |
143 | positive regulation of prostaglandin secretion (GO:0032308) | 2.46843570 |
144 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.46552972 |
145 | purine-containing compound salvage (GO:0043101) | 2.46289065 |
146 | regulation of protein glycosylation (GO:0060049) | 2.44518421 |
147 | protein deneddylation (GO:0000338) | 2.44050521 |
148 | tryptophan metabolic process (GO:0006568) | 2.42686792 |
149 | C-terminal protein amino acid modification (GO:0018410) | 2.41966186 |
150 | tryptophan catabolic process (GO:0006569) | 2.40754048 |
151 | indole-containing compound catabolic process (GO:0042436) | 2.40754048 |
152 | indolalkylamine catabolic process (GO:0046218) | 2.40754048 |
153 | positive regulation of vasculogenesis (GO:2001214) | 2.40617512 |
154 | protein neddylation (GO:0045116) | 2.40602490 |
155 | respiratory chain complex IV assembly (GO:0008535) | 2.37392241 |
156 | regulation of hexokinase activity (GO:1903299) | 2.36756464 |
157 | regulation of glucokinase activity (GO:0033131) | 2.36756464 |
158 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.35728178 |
159 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.34920605 |
160 | lactate metabolic process (GO:0006089) | 2.34817714 |
161 | histamine secretion (GO:0001821) | 2.30803469 |
162 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.27704599 |
163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.25740126 |
164 | kynurenine metabolic process (GO:0070189) | 2.25087579 |
165 | germ cell migration (GO:0008354) | 2.23508253 |
166 | ribosome assembly (GO:0042255) | 2.23290119 |
167 | indolalkylamine metabolic process (GO:0006586) | 2.23163972 |
168 | protein targeting to Golgi (GO:0000042) | 2.22090887 |
169 | purine nucleotide salvage (GO:0032261) | 2.22001859 |
170 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.20322225 |
171 | inositol phosphate dephosphorylation (GO:0046855) | 2.20131448 |
172 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.20131448 |
173 | cytochrome complex assembly (GO:0017004) | 2.20053724 |
174 | positive regulation of DNA recombination (GO:0045911) | 2.18444760 |
175 | dendritic cell migration (GO:0036336) | 2.18030698 |
176 | histone mRNA metabolic process (GO:0008334) | 2.17855258 |
177 | male meiosis I (GO:0007141) | 2.17634698 |
178 | blood vessel maturation (GO:0001955) | 2.17349748 |
179 | protein K11-linked ubiquitination (GO:0070979) | 2.17328459 |
180 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.16152890 |
181 | inositol phosphate catabolic process (GO:0071545) | 2.15233379 |
182 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.14945209 |
183 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.14833392 |
184 | protein K6-linked ubiquitination (GO:0085020) | 2.14540974 |
185 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.14488449 |
186 | regulation of prostaglandin secretion (GO:0032306) | 2.14107697 |
187 | mast cell activation (GO:0045576) | 2.13455500 |
188 | dopamine transport (GO:0015872) | 2.12972176 |
189 | glycolipid biosynthetic process (GO:0009247) | 2.12366857 |
190 | regulation of interleukin-8 secretion (GO:2000482) | 2.12074400 |
191 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.11870169 |
192 | ether lipid metabolic process (GO:0046485) | 2.10818714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.49748209 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.23272560 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.19464089 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.47486043 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.40044197 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.81323313 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17561546 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.08672755 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06794735 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03069141 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91606553 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88720398 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85680296 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75958624 |
15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72927146 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.70090393 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.69556523 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60407124 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55292010 |
20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47733993 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.33692638 |
22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.27140254 |
23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.25103584 |
24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17811565 |
25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.15128345 |
26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05854756 |
27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01783450 |
28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.97435094 |
29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96915908 |
30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88232798 |
31 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87393036 |
32 | MYB_26560356_Chip-Seq_TH2_Human | 1.87151868 |
33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86690777 |
34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86616264 |
35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85537798 |
36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82101217 |
37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78908644 |
38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72843908 |
39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.68774798 |
40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.68488723 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66898383 |
42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65957854 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64268963 |
44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63886788 |
45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.60396246 |
46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60273421 |
47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60036443 |
48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57277036 |
49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.55616890 |
50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54189331 |
51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51901284 |
52 | MYB_26560356_Chip-Seq_TH1_Human | 1.49140264 |
53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47174370 |
54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45586604 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45105714 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45038851 |
57 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.41762028 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39441405 |
59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37102252 |
60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36458254 |
61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35760703 |
62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34934653 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34765969 |
64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33972892 |
65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33316168 |
66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32445297 |
67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32120943 |
68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32071839 |
69 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32071839 |
70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31426930 |
71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31139774 |
72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30750740 |
73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30409732 |
74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30120638 |
75 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29888097 |
76 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28068788 |
77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27006561 |
78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25616579 |
79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25588575 |
80 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20841955 |
81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20426551 |
82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18886700 |
83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18290080 |
84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18251407 |
85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17720887 |
86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16794724 |
87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16563740 |
88 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.16430254 |
89 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16430254 |
90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16001852 |
91 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15937925 |
92 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15164456 |
93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14950250 |
94 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14542978 |
95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14195214 |
96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14169165 |
97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13392870 |
98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13174749 |
99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12728236 |
100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12143676 |
101 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12135915 |
102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11705229 |
103 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10620453 |
104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09593860 |
105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09473705 |
106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09182881 |
107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08997384 |
108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08907789 |
109 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08684071 |
110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08628899 |
111 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08587556 |
112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07798783 |
113 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07431820 |
114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07362047 |
115 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06818835 |
116 | MAF_26560356_Chip-Seq_TH1_Human | 1.05319481 |
117 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05044726 |
118 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05044726 |
119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04833228 |
120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03907842 |
121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03855278 |
122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03275172 |
123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03275172 |
124 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03192747 |
125 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02602112 |
126 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02499402 |
127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02214978 |
128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02138345 |
129 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02022895 |
130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01988857 |
131 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01786786 |
132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01407931 |
133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01217327 |
134 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99897464 |
135 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99850124 |
136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98693233 |
137 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98675919 |
138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98607085 |
139 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.97663716 |
140 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96771205 |
141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94110663 |
142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93930640 |
143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93930640 |
144 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93116148 |
145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91184437 |
146 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90368946 |
147 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89507496 |
148 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89107427 |
149 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86783311 |
150 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83928440 |
151 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83531236 |
152 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82646077 |
153 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80825480 |
154 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80342580 |
155 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80114716 |
156 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79619761 |
157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79434042 |
158 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.79358758 |
159 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76891576 |
160 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76043940 |
161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75674949 |
162 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.69631653 |
163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69588185 |
164 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68253440 |
165 | UTX_26944678_Chip-Seq_JUKART_Human | 0.67565356 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.28624731 |
2 | MP0001835_abnormal_antigen_presentation | 4.13876607 |
3 | MP0009785_altered_susceptibility_to | 3.86504623 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.23538647 |
5 | MP0000685_abnormal_immune_system | 3.04309277 |
6 | MP0003436_decreased_susceptibility_to | 2.92627042 |
7 | MP0005671_abnormal_response_to | 2.71891235 |
8 | MP0005000_abnormal_immune_tolerance | 2.70556959 |
9 | MP0005025_abnormal_response_to | 2.61472347 |
10 | MP0005387_immune_system_phenotype | 2.60974280 |
11 | MP0001790_abnormal_immune_system | 2.60974280 |
12 | MP0002419_abnormal_innate_immunity | 2.60592664 |
13 | MP0006082_CNS_inflammation | 2.57099752 |
14 | MP0003950_abnormal_plasma_membrane | 2.52524940 |
15 | MP0002006_tumorigenesis | 2.45386436 |
16 | MP0002452_abnormal_antigen_presenting | 2.27155757 |
17 | MP0002166_altered_tumor_susceptibility | 2.24411859 |
18 | MP0002723_abnormal_immune_serum | 2.19128022 |
19 | MP0001800_abnormal_humoral_immune | 2.17660652 |
20 | MP0001819_abnormal_immune_cell | 2.04166955 |
21 | MP0008877_abnormal_DNA_methylation | 2.02993299 |
22 | MP0002420_abnormal_adaptive_immunity | 2.01648258 |
23 | MP0009764_decreased_sensitivity_to | 1.93770943 |
24 | MP0003806_abnormal_nucleotide_metabolis | 1.88456942 |
25 | MP0008058_abnormal_DNA_repair | 1.80912525 |
26 | MP0002877_abnormal_melanocyte_morpholog | 1.79677865 |
27 | MP0001853_heart_inflammation | 1.79649820 |
28 | MP0002138_abnormal_hepatobiliary_system | 1.78445636 |
29 | MP0001533_abnormal_skeleton_physiology | 1.77952355 |
30 | MP0004947_skin_inflammation | 1.74971446 |
31 | MP0010234_abnormal_vibrissa_follicle | 1.71587566 |
32 | MP0006072_abnormal_retinal_apoptosis | 1.71170260 |
33 | MP0002405_respiratory_system_inflammati | 1.70620744 |
34 | MP0002254_reproductive_system_inflammat | 1.69456414 |
35 | MP0001845_abnormal_inflammatory_respons | 1.69364216 |
36 | MP0003763_abnormal_thymus_physiology | 1.63960124 |
37 | MP0003252_abnormal_bile_duct | 1.62175778 |
38 | MP0002102_abnormal_ear_morphology | 1.60339404 |
39 | MP0010155_abnormal_intestine_physiology | 1.57157156 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.56327877 |
41 | MP0002139_abnormal_hepatobiliary_system | 1.56134652 |
42 | MP0000858_altered_metastatic_potential | 1.56032140 |
43 | MP0003448_altered_tumor_morphology | 1.54982655 |
44 | MP0008469_abnormal_protein_level | 1.54212260 |
45 | MP0010678_abnormal_skin_adnexa | 1.49641612 |
46 | MP0006054_spinal_hemorrhage | 1.48557903 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.48553822 |
48 | MP0000716_abnormal_immune_system | 1.48322005 |
49 | MP0001879_abnormal_lymphatic_vessel | 1.48235706 |
50 | MP0004510_myositis | 1.47544599 |
51 | MP0005084_abnormal_gallbladder_morpholo | 1.46661974 |
52 | MP0008057_abnormal_DNA_replication | 1.45050144 |
53 | MP0002398_abnormal_bone_marrow | 1.44966773 |
54 | MP0005464_abnormal_platelet_physiology | 1.40958584 |
55 | MP0002876_abnormal_thyroid_physiology | 1.38127731 |
56 | MP0000343_altered_response_to | 1.36935889 |
57 | MP0003191_abnormal_cellular_cholesterol | 1.36550576 |
58 | MP0003828_pulmonary_edema | 1.36376206 |
59 | MP0004782_abnormal_surfactant_physiolog | 1.34034094 |
60 | MP0002837_dystrophic_cardiac_calcinosis | 1.29599175 |
61 | MP0003186_abnormal_redox_activity | 1.26907999 |
62 | MP0002132_abnormal_respiratory_system | 1.25742449 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.23899577 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.22298914 |
65 | MP0001545_abnormal_hematopoietic_system | 1.22028532 |
66 | MP0005397_hematopoietic_system_phenotyp | 1.22028532 |
67 | MP0006036_abnormal_mitochondrial_physio | 1.19505850 |
68 | MP0002429_abnormal_blood_cell | 1.19021070 |
69 | MP0003303_peritoneal_inflammation | 1.17322537 |
70 | MP0005310_abnormal_salivary_gland | 1.17274883 |
71 | MP0002163_abnormal_gland_morphology | 1.16541327 |
72 | MP0002998_abnormal_bone_remodeling | 1.16478602 |
73 | MP0000689_abnormal_spleen_morphology | 1.16340962 |
74 | MP0005058_abnormal_lysosome_morphology | 1.16284997 |
75 | MP0001873_stomach_inflammation | 1.15899911 |
76 | MP0002722_abnormal_immune_system | 1.12490254 |
77 | MP0005253_abnormal_eye_physiology | 1.11589580 |
78 | MP0010386_abnormal_urinary_bladder | 1.08511462 |
79 | MP0003718_maternal_effect | 1.08075314 |
80 | MP0000516_abnormal_urinary_system | 1.05727541 |
81 | MP0005367_renal/urinary_system_phenotyp | 1.05727541 |
82 | MP0002095_abnormal_skin_pigmentation | 1.04827842 |
83 | MP0005164_abnormal_response_to | 1.04648171 |
84 | MP0000569_abnormal_digit_pigmentation | 1.03906754 |
85 | MP0004484_altered_response_of | 1.03559858 |
86 | MP0000465_gastrointestinal_hemorrhage | 1.03280758 |
87 | MP0002933_joint_inflammation | 1.02539206 |
88 | MP0003786_premature_aging | 1.00878773 |
89 | MP0009278_abnormal_bone_marrow | 0.98975568 |
90 | MP0004808_abnormal_hematopoietic_stem | 0.98945660 |
91 | MP0000427_abnormal_hair_cycle | 0.98856692 |
92 | MP0005167_abnormal_blood-brain_barrier | 0.97487983 |
93 | MP0000767_abnormal_smooth_muscle | 0.97215127 |
94 | MP0005390_skeleton_phenotype | 0.97164817 |
95 | MP0002396_abnormal_hematopoietic_system | 0.96620570 |
96 | MP0001851_eye_inflammation | 0.96091943 |
97 | MP0005410_abnormal_fertilization | 0.95470850 |
98 | MP0010368_abnormal_lymphatic_system | 0.94848425 |
99 | MP0002693_abnormal_pancreas_physiology | 0.93872324 |
100 | MP0005166_decreased_susceptibility_to | 0.93624742 |
101 | MP0006035_abnormal_mitochondrial_morpho | 0.92830182 |
102 | MP0008007_abnormal_cellular_replicative | 0.92273772 |
103 | MP0005275_abnormal_skin_tensile | 0.91541546 |
104 | MP0000249_abnormal_blood_vessel | 0.91014555 |
105 | MP0000383_abnormal_hair_follicle | 0.90227529 |
106 | MP0002009_preneoplasia | 0.88724182 |
107 | MP0003300_gastrointestinal_ulcer | 0.87645961 |
108 | MP0009763_increased_sensitivity_to | 0.86529977 |
109 | MP0005379_endocrine/exocrine_gland_phen | 0.86189970 |
110 | MP0004147_increased_porphyrin_level | 0.85659146 |
111 | MP0000372_irregular_coat_pigmentation | 0.81081352 |
112 | MP0001764_abnormal_homeostasis | 0.80436542 |
113 | MP0009780_abnormal_chondrocyte_physiolo | 0.80322502 |
114 | MP0004134_abnormal_chest_morphology | 0.78809777 |
115 | MP0008260_abnormal_autophagy | 0.78356028 |
116 | MP0003183_abnormal_peptide_metabolism | 0.78022521 |
117 | MP0003566_abnormal_cell_adhesion | 0.77539484 |
118 | MP0000703_abnormal_thymus_morphology | 0.77367210 |
119 | MP0003075_altered_response_to | 0.76969149 |
120 | MP0004215_abnormal_myocardial_fiber | 0.76860487 |
121 | MP0001881_abnormal_mammary_gland | 0.76039955 |
122 | MP0003195_calcinosis | 0.71961303 |
123 | MP0004883_abnormal_blood_vessel | 0.71095827 |
124 | MP0003795_abnormal_bone_structure | 0.70933609 |
125 | MP0001191_abnormal_skin_condition | 0.69518922 |
126 | MP0009697_abnormal_copulation | 0.67067752 |
127 | MP0010352_gastrointestinal_tract_polyps | 0.64146699 |
128 | MP0003453_abnormal_keratinocyte_physiol | 0.63333041 |
129 | MP0008438_abnormal_cutaneous_collagen | 0.63265680 |
130 | MP0003045_fibrosis | 0.62707711 |
131 | MP0005174_abnormal_tail_pigmentation | 0.61353368 |
132 | MP0000015_abnormal_ear_pigmentation | 0.60336665 |
133 | MP0005408_hypopigmentation | 0.58623868 |
134 | MP0002019_abnormal_tumor_incidence | 0.58571981 |
135 | MP0000627_abnormal_mammary_gland | 0.58010139 |
136 | MP0003866_abnormal_defecation | 0.57374599 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.76282419 |
2 | Recurrent abscess formation (HP:0002722) | 5.36433783 |
3 | Myositis (HP:0100614) | 4.87202254 |
4 | Orchitis (HP:0100796) | 4.76198465 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.72917957 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.66095608 |
7 | Optic neuritis (HP:0100653) | 4.66095608 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58226021 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.36485196 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.80689516 |
11 | Increased IgM level (HP:0003496) | 3.60578822 |
12 | Abnormality of macrophages (HP:0004311) | 3.58846131 |
13 | Recurrent fungal infections (HP:0002841) | 3.53796553 |
14 | Autoimmune thrombocytopenia (HP:0001973) | 3.45266995 |
15 | Vacuolated lymphocytes (HP:0001922) | 3.28431921 |
16 | Metaphyseal dysplasia (HP:0100255) | 3.18361584 |
17 | Recurrent skin infections (HP:0001581) | 3.17193309 |
18 | Vasculitis (HP:0002633) | 3.16410952 |
19 | Recurrent viral infections (HP:0004429) | 3.14189792 |
20 | Type I transferrin isoform profile (HP:0003642) | 3.11016662 |
21 | Eosinophilia (HP:0001880) | 3.05907025 |
22 | Periodontitis (HP:0000704) | 3.01652544 |
23 | Keratoconjunctivitis sicca (HP:0001097) | 3.00853209 |
24 | Pulmonary infiltrates (HP:0002113) | 2.94795760 |
25 | Stomatitis (HP:0010280) | 2.93241479 |
26 | Vertebral compression fractures (HP:0002953) | 2.92897387 |
27 | Hypergammaglobulinemia (HP:0010702) | 2.92809751 |
28 | Abnormality of the prostate (HP:0008775) | 2.91584950 |
29 | Hemoptysis (HP:0002105) | 2.90593271 |
30 | Gingivitis (HP:0000230) | 2.86814735 |
31 | Abnormal protein glycosylation (HP:0012346) | 2.83922726 |
32 | Abnormal glycosylation (HP:0012345) | 2.83922726 |
33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.83922726 |
34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.83922726 |
35 | Keratoconjunctivitis (HP:0001096) | 2.83797216 |
36 | Stomach cancer (HP:0012126) | 2.81367965 |
37 | Arterial thrombosis (HP:0004420) | 2.80531475 |
38 | Basal ganglia calcification (HP:0002135) | 2.79687347 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.78920923 |
40 | Methylmalonic acidemia (HP:0002912) | 2.75048696 |
41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68790741 |
42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68790741 |
43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68790741 |
44 | Volvulus (HP:0002580) | 2.64627701 |
45 | Granulocytopenia (HP:0001913) | 2.63438565 |
46 | Gastrointestinal infarctions (HP:0005244) | 2.62083031 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61243235 |
48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61243235 |
49 | Obstructive lung disease (HP:0006536) | 2.59398322 |
50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59398322 |
51 | Leukocytosis (HP:0001974) | 2.59017063 |
52 | Joint swelling (HP:0001386) | 2.54444551 |
53 | Systemic lupus erythematosus (HP:0002725) | 2.54348745 |
54 | Abnormality of eosinophils (HP:0001879) | 2.50696450 |
55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48946884 |
56 | Abnormality of T cell number (HP:0011839) | 2.47349129 |
57 | Syringomyelia (HP:0003396) | 2.46008893 |
58 | Spinal cord lesions (HP:0100561) | 2.46008893 |
59 | Meningitis (HP:0001287) | 2.43578827 |
60 | Renal cortical cysts (HP:0000803) | 2.39543919 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 2.38105203 |
62 | Tetraparesis (HP:0002273) | 2.34164031 |
63 | Progressive macrocephaly (HP:0004481) | 2.32376881 |
64 | Thyroiditis (HP:0100646) | 2.32359066 |
65 | Thrombocytosis (HP:0001894) | 2.29143904 |
66 | Methylmalonic aciduria (HP:0012120) | 2.28149814 |
67 | Aplastic anemia (HP:0001915) | 2.27562675 |
68 | Spontaneous hematomas (HP:0007420) | 2.24772385 |
69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24548632 |
70 | Increased CSF lactate (HP:0002490) | 2.20858551 |
71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19269896 |
72 | Abnormality of the nasal mucosa (HP:0000433) | 2.18616058 |
73 | Gangrene (HP:0100758) | 2.18042678 |
74 | Encephalitis (HP:0002383) | 2.17824925 |
75 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.16141951 |
76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.16141951 |
77 | Urticaria (HP:0001025) | 2.15647149 |
78 | IgM deficiency (HP:0002850) | 2.14098473 |
79 | Progressive inability to walk (HP:0002505) | 2.14046702 |
80 | Severe combined immunodeficiency (HP:0004430) | 2.12169467 |
81 | Osteomyelitis (HP:0002754) | 2.12019790 |
82 | Recurrent pneumonia (HP:0006532) | 2.11857744 |
83 | Abnormality of T cells (HP:0002843) | 2.11123966 |
84 | T lymphocytopenia (HP:0005403) | 2.10377378 |
85 | Chronic otitis media (HP:0000389) | 2.09151337 |
86 | Petechiae (HP:0000967) | 2.09029282 |
87 | Mitochondrial inheritance (HP:0001427) | 2.08685894 |
88 | Abnormal spermatogenesis (HP:0008669) | 2.08355105 |
89 | Acute necrotizing encephalopathy (HP:0006965) | 2.08212331 |
90 | Anorexia (HP:0002039) | 2.06929694 |
91 | Anhidrosis (HP:0000970) | 2.06664595 |
92 | Increased IgE level (HP:0003212) | 2.05517663 |
93 | Abnormality of T cell physiology (HP:0011840) | 2.05270998 |
94 | Abnormality of the renal cortex (HP:0011035) | 2.04509745 |
95 | Parakeratosis (HP:0001036) | 2.02365820 |
96 | Hypothermia (HP:0002045) | 2.01302298 |
97 | Recurrent bronchitis (HP:0002837) | 2.01080568 |
98 | Attenuation of retinal blood vessels (HP:0007843) | 2.00920280 |
99 | Abnormality of B cell number (HP:0010975) | 2.00497676 |
100 | B lymphocytopenia (HP:0010976) | 2.00497676 |
101 | Abnormality of the pericardium (HP:0001697) | 2.00118732 |
102 | Constricted visual fields (HP:0001133) | 1.99712753 |
103 | Short tibia (HP:0005736) | 1.99242747 |
104 | Cellulitis (HP:0100658) | 1.98743845 |
105 | Abnormality of methionine metabolism (HP:0010901) | 1.97215260 |
106 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97166640 |
107 | Purpura (HP:0000979) | 1.96661589 |
108 | Myocardial infarction (HP:0001658) | 1.95646222 |
109 | Molar tooth sign on MRI (HP:0002419) | 1.95520493 |
110 | Abnormality of midbrain morphology (HP:0002418) | 1.95520493 |
111 | Pustule (HP:0200039) | 1.95311942 |
112 | Spondylolisthesis (HP:0003302) | 1.95280803 |
113 | Keratitis (HP:0000491) | 1.94221138 |
114 | Nasal polyposis (HP:0100582) | 1.93509111 |
115 | Combined immunodeficiency (HP:0005387) | 1.93068728 |
116 | Abnormality of the axillary hair (HP:0100134) | 1.92153396 |
117 | Abnormality of secondary sexual hair (HP:0009888) | 1.92153396 |
118 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92151745 |
119 | Hypoproteinemia (HP:0003075) | 1.91689347 |
120 | Median cleft lip (HP:0000161) | 1.91593701 |
121 | Increased cerebral lipofuscin (HP:0011813) | 1.91086264 |
122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.90949483 |
123 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90366195 |
124 | Osteolytic defects of the hand bones (HP:0009699) | 1.90366195 |
125 | Prostate neoplasm (HP:0100787) | 1.90296302 |
126 | Reduced antithrombin III activity (HP:0001976) | 1.89005144 |
127 | Medial flaring of the eyebrow (HP:0010747) | 1.88957974 |
128 | IgG deficiency (HP:0004315) | 1.88783859 |
129 | Cerebral edema (HP:0002181) | 1.88691918 |
130 | Abnormality of the pleura (HP:0002103) | 1.87540741 |
131 | Short middle phalanx of the 5th finger (HP:0004220) | 1.87442695 |
132 | Chronic diarrhea (HP:0002028) | 1.87433566 |
133 | Azoospermia (HP:0000027) | 1.87098299 |
134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86832135 |
135 | Neonatal respiratory distress (HP:0002643) | 1.86368089 |
136 | Poor head control (HP:0002421) | 1.85619374 |
137 | Hepatic necrosis (HP:0002605) | 1.85488743 |
138 | Facial diplegia (HP:0001349) | 1.84887717 |
139 | Esophageal neoplasm (HP:0100751) | 1.84482909 |
140 | Neoplasm of head and neck (HP:0012288) | 1.84482909 |
141 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.84313508 |
142 | Alveolar cell carcinoma (HP:0006519) | 1.83794895 |
143 | Cutaneous melanoma (HP:0012056) | 1.83500750 |
144 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83287717 |
145 | Neutropenia (HP:0001875) | 1.82969750 |
146 | Hematochezia (HP:0002573) | 1.82350963 |
147 | Glomerulopathy (HP:0100820) | 1.82312002 |
148 | Fair hair (HP:0002286) | 1.80920367 |
149 | Absent speech (HP:0001344) | 1.80692117 |
150 | Hypoplasia of the thymus (HP:0000778) | 1.80086728 |
151 | Hepatocellular necrosis (HP:0001404) | 1.79622380 |
152 | Pancreatic cysts (HP:0001737) | 1.78557534 |
153 | Abnormality of vitamin B metabolism (HP:0004340) | 1.77910120 |
154 | Skin ulcer (HP:0200042) | 1.77739981 |
155 | Arthralgia (HP:0002829) | 1.77260538 |
156 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77209565 |
157 | Intestinal atresia (HP:0011100) | 1.76798473 |
158 | Increased serum lactate (HP:0002151) | 1.74469224 |
159 | Abnormality of chromosome stability (HP:0003220) | 1.73005801 |
160 | Conjunctival hamartoma (HP:0100780) | 1.71612586 |
161 | Acute encephalopathy (HP:0006846) | 1.70984063 |
162 | Widely spaced teeth (HP:0000687) | 1.70953612 |
163 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69722115 |
164 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.69111706 |
165 | Lipid accumulation in hepatocytes (HP:0006561) | 1.68489829 |
166 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.68228995 |
167 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.67702775 |
168 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66937581 |
169 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66665674 |
170 | Albinism (HP:0001022) | 1.65992419 |
171 | Patchy hypopigmentation of hair (HP:0011365) | 1.64904039 |
172 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.64283426 |
173 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.64164703 |
174 | Hyperalaninemia (HP:0003348) | 1.63435674 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.48790361 |
2 | TXK | 3.30327251 |
3 | JAK3 | 3.05169559 |
4 | TYK2 | 2.87831124 |
5 | MAP4K2 | 2.69203626 |
6 | MST4 | 2.41569648 |
7 | TBK1 | 2.40414868 |
8 | IKBKE | 2.34553913 |
9 | IRAK3 | 2.22433242 |
10 | MAP4K1 | 2.17481653 |
11 | EIF2AK3 | 2.10357572 |
12 | IRAK4 | 2.04249407 |
13 | TRIM28 | 2.00540502 |
14 | IKBKB | 1.97553836 |
15 | KDR | 1.88386614 |
16 | JAK1 | 1.84450549 |
17 | RIPK4 | 1.84161218 |
18 | PIM2 | 1.83476190 |
19 | PINK1 | 1.80420670 |
20 | ZAP70 | 1.80157913 |
21 | KIT | 1.78346216 |
22 | PLK4 | 1.74729199 |
23 | FLT3 | 1.72780032 |
24 | TGFBR2 | 1.72266510 |
25 | BLK | 1.69903908 |
26 | ERN1 | 1.67786124 |
27 | BCKDK | 1.65698103 |
28 | EPHA3 | 1.60135899 |
29 | CHUK | 1.57180105 |
30 | TEC | 1.56119895 |
31 | ACVR1B | 1.55001145 |
32 | GRK1 | 1.53371840 |
33 | PLK2 | 1.46923987 |
34 | PBK | 1.44258834 |
35 | FGFR4 | 1.42505279 |
36 | TIE1 | 1.41379992 |
37 | WNK3 | 1.41294199 |
38 | PIK3CG | 1.35047857 |
39 | NLK | 1.34210959 |
40 | BMPR2 | 1.32662521 |
41 | EIF2AK2 | 1.32438061 |
42 | NEK9 | 1.31524162 |
43 | BTK | 1.28400799 |
44 | TAOK3 | 1.26538182 |
45 | ERBB3 | 1.25044626 |
46 | FGFR3 | 1.22571444 |
47 | CSK | 1.22497361 |
48 | MAP3K3 | 1.20713007 |
49 | SYK | 1.13704248 |
50 | MAP3K13 | 1.11838598 |
51 | TGFBR1 | 1.09649495 |
52 | NUAK1 | 1.06241762 |
53 | MAP3K12 | 1.04400641 |
54 | LCK | 1.01420938 |
55 | RPS6KA4 | 0.99328216 |
56 | EPHB1 | 0.99104827 |
57 | STK38L | 0.98452164 |
58 | NME2 | 0.97766826 |
59 | YES1 | 0.97282818 |
60 | FER | 0.94420233 |
61 | BUB1 | 0.93909114 |
62 | LYN | 0.93477394 |
63 | PIM1 | 0.92340345 |
64 | STK10 | 0.88446833 |
65 | INSRR | 0.85127006 |
66 | PRKCE | 0.84980705 |
67 | RIPK1 | 0.83900542 |
68 | HCK | 0.83567955 |
69 | STK39 | 0.82034058 |
70 | JAK2 | 0.81933944 |
71 | CSNK1G1 | 0.81141815 |
72 | PDK2 | 0.80584988 |
73 | PLK3 | 0.79114120 |
74 | MUSK | 0.78973114 |
75 | MYLK | 0.78651346 |
76 | NEK1 | 0.77794055 |
77 | ITK | 0.77615070 |
78 | STK24 | 0.77076233 |
79 | SRPK1 | 0.76536619 |
80 | FRK | 0.75059982 |
81 | OXSR1 | 0.73444442 |
82 | TNIK | 0.73067296 |
83 | MKNK1 | 0.72398881 |
84 | PTK6 | 0.71970545 |
85 | CSF1R | 0.70976640 |
86 | BRSK2 | 0.70360426 |
87 | PRKG2 | 0.69940214 |
88 | MARK3 | 0.67515532 |
89 | CSNK1G3 | 0.64985307 |
90 | TESK1 | 0.64966165 |
91 | STK3 | 0.64673875 |
92 | CAMKK2 | 0.63146962 |
93 | BCR | 0.62765943 |
94 | IRAK1 | 0.62012872 |
95 | CSNK1G2 | 0.60545200 |
96 | MATK | 0.60048769 |
97 | PRKCD | 0.58609838 |
98 | MST1R | 0.57443657 |
99 | GRK6 | 0.57320803 |
100 | TRPM7 | 0.57172231 |
101 | MKNK2 | 0.56938149 |
102 | ADRBK2 | 0.56934877 |
103 | ZAK | 0.56400838 |
104 | MAPK13 | 0.54153279 |
105 | RPS6KA5 | 0.53731940 |
106 | GRK7 | 0.53047503 |
107 | BMPR1B | 0.52576919 |
108 | DYRK3 | 0.51360501 |
109 | ADRBK1 | 0.50649234 |
110 | PRKCQ | 0.50177281 |
111 | MAPKAPK5 | 0.49398536 |
112 | CDK8 | 0.49374506 |
113 | PASK | 0.49341562 |
114 | VRK1 | 0.49318651 |
115 | MAPKAPK3 | 0.48078828 |
116 | MAPKAPK2 | 0.47874388 |
117 | EGFR | 0.46844225 |
118 | IGF1R | 0.46122060 |
119 | EIF2AK1 | 0.45233275 |
120 | * ABL1 | 0.45187351 |
121 | STK4 | 0.44335931 |
122 | NEK6 | 0.41564493 |
123 | OBSCN | 0.41563498 |
124 | FES | 0.38439154 |
125 | CDK6 | 0.36101851 |
126 | SIK3 | 0.35779032 |
127 | CSNK1A1L | 0.33662645 |
128 | CDK19 | 0.32953548 |
129 | ATM | 0.32213123 |
130 | WEE1 | 0.31652557 |
131 | MAP2K3 | 0.29300055 |
132 | LRRK2 | 0.26745615 |
133 | ABL2 | 0.26126456 |
134 | EPHA2 | 0.25845119 |
135 | PTK2B | 0.25025791 |
136 | MOS | 0.25019416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.84443023 |
2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.00185455 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.90272215 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.86647122 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82282861 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77753554 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58245106 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.53331100 |
9 | Malaria_Homo sapiens_hsa05144 | 2.41164756 |
10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.40097161 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.38591389 |
12 | Measles_Homo sapiens_hsa05162 | 2.38508768 |
13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.33127156 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26633852 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18917612 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.18292856 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17387554 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.10081262 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09812815 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08938630 |
21 | Pertussis_Homo sapiens_hsa05133 | 2.04269912 |
22 | Proteasome_Homo sapiens_hsa03050 | 1.84959838 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82001501 |
24 | Protein export_Homo sapiens_hsa03060 | 1.81854443 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.79554716 |
26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78819381 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77926084 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76512923 |
29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74187175 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74058664 |
31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.69402029 |
32 | Homologous recombination_Homo sapiens_hsa03440 | 1.67666598 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.67275778 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65606165 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63683791 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.62023674 |
37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61011422 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60991412 |
39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.59811540 |
40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58089499 |
41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57897179 |
42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.56742828 |
43 | Phototransduction_Homo sapiens_hsa04744 | 1.51086020 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48561354 |
45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47980285 |
46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42235122 |
47 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38762070 |
48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34239546 |
49 | Asthma_Homo sapiens_hsa05310 | 1.33320944 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 1.33317249 |
51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32823223 |
52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.31291868 |
53 | RNA degradation_Homo sapiens_hsa03018 | 1.30803893 |
54 | Phagosome_Homo sapiens_hsa04145 | 1.25935544 |
55 | Apoptosis_Homo sapiens_hsa04210 | 1.20753732 |
56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19320208 |
57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18790130 |
58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18176788 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 1.17458691 |
60 | Shigellosis_Homo sapiens_hsa05131 | 1.15111777 |
61 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11124982 |
62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11105426 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10709362 |
64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06193930 |
65 | RNA polymerase_Homo sapiens_hsa03020 | 1.05597373 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04026025 |
67 | Mismatch repair_Homo sapiens_hsa03430 | 1.03786362 |
68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01998998 |
69 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01383274 |
70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98806009 |
71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96440450 |
72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95771654 |
73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95671244 |
74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94008604 |
75 | Lysosome_Homo sapiens_hsa04142 | 0.92665552 |
76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91380820 |
77 | Hepatitis C_Homo sapiens_hsa05160 | 0.91143842 |
78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90869021 |
79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89913527 |
80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87188504 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86465026 |
82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80140931 |
83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78439906 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73944995 |
85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73912797 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71523857 |
87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70968930 |
88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70813800 |
89 | Peroxisome_Homo sapiens_hsa04146 | 0.70430118 |
90 | RNA transport_Homo sapiens_hsa03013 | 0.70357446 |
91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69804479 |
92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63335194 |
93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61308209 |
94 | Amoebiasis_Homo sapiens_hsa05146 | 0.61224522 |
95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59765606 |
96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59764194 |
97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59275887 |
98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58869405 |
99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56908034 |
100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56510792 |
101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55971840 |
102 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55401037 |
103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54518221 |
104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54375818 |
105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54257972 |
106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53785283 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53306425 |
108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50905422 |
109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50548308 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49012481 |
111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48913490 |
112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48254062 |
113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47959709 |
114 | Platelet activation_Homo sapiens_hsa04611 | 0.47828977 |
115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47423606 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46496903 |
117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44511406 |
118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44188074 |
119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43871184 |
120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43518218 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43321994 |
122 | Purine metabolism_Homo sapiens_hsa00230 | 0.42472791 |
123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41664741 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41313909 |
125 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40877047 |
126 | Spliceosome_Homo sapiens_hsa03040 | 0.39022435 |
127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38569940 |
128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38186457 |
129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36964422 |
130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36627202 |
131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33496789 |
132 | Ribosome_Homo sapiens_hsa03010 | 0.33267001 |
133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32225196 |
134 | Prion diseases_Homo sapiens_hsa05020 | 0.32107215 |
135 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30243834 |
136 | DNA replication_Homo sapiens_hsa03030 | 0.24583193 |
137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24564738 |
138 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.24019839 |
139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22838984 |
140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21781737 |
141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21578471 |
142 | Base excision repair_Homo sapiens_hsa03410 | 0.18706294 |
143 | Adherens junction_Homo sapiens_hsa04520 | 0.18277543 |
144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17649910 |
145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15572941 |
146 | Insulin resistance_Homo sapiens_hsa04931 | 0.14486798 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13179824 |
148 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13027352 |
149 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12220889 |
150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11931493 |
151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11790415 |